Company
Board Member
2023-03-07–present
Björn Odlander
Board Member
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Björn Odlander
The company reported in an 8-K filed July 1, 2024 that Björn Odlander resigned as director, effective June 30, 2024. The company reported in an 8-K filed March 8, 2023 that Björn Odlander was appointed Board, effective March 7, 2023.
“On June 26, 2024, each of Regina Hodits, Ph.D. and Björn Odlander, M.D., Ph.D. notified Carisma Therapeutics Inc. (the "Company") of their respective decisions to resign from the Company's board of directors, effective June 30, 2024.”
“the Board and its committees were reconstituted, consisting of six directors designated by Carisma, who are Steven Kelly, Regina Hodits, Ph.D., Briggs Morrison, M.D., Björn Odlander, M.D., Ph.D., Chidozie Ugwumba and Sanford Zweifach, and one director designated by the Company, who is Michael Torok.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Organization not stated
Board Member
SEC 8-K
Current2023-03-07–present
-
Organization not stated
Board Member
SEC 8-K
2023-06-06–2024-06-30
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
-
Executive change Resigned: director
-
Executive change Appointed: Board